Search Results
Rivaroxaban for thromboprophylaxis in high-risk cancer patients: CASSINI results
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with cancer
Alok A. Khorana: Rivaroxaban Thromboprophylaxis in High-Risk Ambulatory Cancer Patients
Rivaroxaban in high-risk ambulatory cancer patients receiving systemic therapy
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer
Alok Khorana: Rivaroxaban Prevents Cancer-Associated VTE
Rivaroxaban for thromboprophylaxis in high risk ambulatory patients with cancer
Rivaroxaban for Thromboprophylaxis in High Risk Ambulatory Patients with Cancer
Rivaroxaban in Cancer-Associated VTE: Results from CALLISTO
Updated ASCO guidelines for VTE in cancer
How is cancer-related venous thromboembolism treated in real world practice?
Rivaroxaban for preventing venous thromboembolism in high-risk ambulatory patients with cancer
